Dr. Reddy’s and TRPharm announce strategic collaboration in Turkey

March 14, 2016 7:53 AM


Dr. Reddy’s and TRPharm announced a strategic collaboration agreement involving three biosimilar products.

A total of three products will be registered and subsequently commercialized as a part of this agreement by TRPharm in Turkey. TRPharm will also manufacture the drug substance and drug product upon completion of its facility investment.

Mehmet Göker, General Manager of TRPharm said “Biosimilars are a key component of our investment strategy in Turkey to establish biotechnological API production for national use and regional exports. This agreement will not only enable more affordable medication but also support our research and development initiatives by building expertise within the country. We are pleased to have already started laying out the groundwork for manufacturing with Dr. Reddy’s for high quality biosimilar products.”

Ramana MV, Executive Vice President for branded markets at Dr. Reddy’s  Laboratories said “Turkey is a key emerging market and we are pleased to partner with TRPharm to ensure that patients in the region get access to our portfolio of high quality biosimilar products. Dr. Reddy’s Laboratories is and remains committed to providing access to affordable and innovative drugs to populations around the world, and this partnership will make this happen in Turkey.”

TRPharm has begun laying out the groundwork for the technology transfer. This collaboration will be an important component of TRPharm’s ongoing biological product development and manufacturing business in the region. The partnership will also enable Dr. Reddy’s to widen the global footprint of its biosimilar business.

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)

Latest News on Biosimilar News

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?


Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!